Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Atezolizumab 840 MG in 14 ML Injection|DRUG: Atezolizumab 1200 MG in 20 ML Injection|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide|PROCEDURE: Biopsy Arm A|PROCEDURE: Biopsy Arm B|PROCEDURE: Surgery
Sponsor: Palleos Healthcare GmbH
Collaborators: Roche Pharma AG|Phaon Scientific GmbH|University Hospital, Essen|University Hospital Erlangen